Literature DB >> 11565065

Rubella seropositivity in the United States, 1988-1994.

C A Dykewicz1, D Kruszon-Moran, G M McQuillan, W W Williams, F P Van Loon, C Cossen, B Forghani, S C Hadler.   

Abstract

Data obtained in the third National Health and Nutrition Examination Survey (NHANES III), conducted during 1988-1994, were analyzed to determine the epidemiology of rubella seropositivity in the United States, including risk factors for low rubella seropositivity. Serological samples obtained from NHANES III study participants > or =6 years of age were tested for rubella IgG antibodies. "Rubella seropositivity" was defined as serum rubella IgG antibody level > or =10 IU by enzyme immunoassay. Overall, rubella seropositivity rates in the United States were 92% in persons aged 6-11 years, 83% in persons aged 12-19 years, 85% in persons aged 20-29 years, 89% in persons aged 30-39 years, and >or =93% in persons aged > or =40 years. The lowest rate (78%) of any United States birth cohort of the 20th century occurred among persons born from 1970-1974. Eliminating rubella and chronic rubella syndrome in the United States will require international efforts, including vaccination of preschool- and school-age children and all susceptible young adults.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565065     DOI: 10.1086/322651

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  4 in total

1.  Lack of immunity against rubella among Italian young adults.

Authors:  Maria Serena Gallone; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2017-03-07       Impact factor: 3.090

2.  Evaluation of rubella immunity in a community prenatal clinic.

Authors:  Edward C Nwanegbo; Thor Swanson; Oluseyi Vanderpuye; Carlos F Rios-Bedoya
Journal:  ISRN Family Med       Date:  2013-01-15

3.  [Seroprevalence of rubella in Colombia: a birth-year cohort analysis].

Authors:  Doracelly Hincapie-Palacio; Viviana Lenis Ballesteros; Martha Ospina Ospina; Olga Lucía Pérez Toro; Francisco J Díaz
Journal:  Rev Saude Publica       Date:  2013-12       Impact factor: 2.106

4.  Socioeconomic Status Is Associated With Antibody Levels Against Vaccine Preventable Diseases in the Netherlands.

Authors:  Joske Hoes; Anna G C Boef; Mirjam J Knol; Hester E de Melker; Liesbeth Mollema; Fiona R M van der Klis; Nynke Y Rots; Debbie van Baarle
Journal:  Front Public Health       Date:  2018-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.